![]() |
市場調查報告書
商品編碼
2024148
CBD替代保健產品市場預測至2034年-按產品類型、成分類型、劑型、通路、應用、最終用戶和地區分類的全球分析CBD-Alternative Wellness Products Market Forecasts to 2034 - Global Analysis By Product Type, Ingredient Type, Form, Distribution Channel, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球 CBD 替代保健產品市場規模將達到 84 億美元,並在預測期內以 18.4% 的複合年成長率成長,到 2034 年將達到 326 億美元。
CBD替代保健產品包括草藥補充劑、功能性飲料、外用製劑、芳香療法配方和食用保健產品。這些產品含有大麻以外的生物活性成分,例如適應原草藥、藥用蘑菇提取物、植物來源的舒緩壓力化合物、氨基酸前體和微量營養素複合物。它們透過植物植物來源。
監理不確定性及CBD替代方案
多個國際市場對CBD監管的持續不確定性導致CBD保健產品的供應鏈不穩定、標籤複雜化以及分銷管道受限。然而,這卻直接惠及了適應原、真菌和草本CBD替代植物保健品牌。這些品牌在更清晰、更寬鬆的法規結構下運作。擔心CBD合規複雜性的零售商正積極拓展CBD替代功能性保健產品的供應,將其作為風險較低的替代方案,以滿足消費者緩解壓力和焦慮的相同需求。
消費者對CBD偏好的慣性
消費者對CBD保健產品定位的既定認知,以及內生性大麻素系統作用機制的廣泛認知,使得CBD替代品牌亟需強化消費者教育。為了使CBD替代品牌的價格和保健功效定位能夠與CBD領域先驅品牌投入的大量宣傳力度相媲美,消費者必須對適應原、益智藥和藥用蘑菇的化學機制有類似的理解。
主流零售分銷網路的擴張
將適應原和功能性植物來源保健產品拓展到主流超市、藥局和量販店通路,蘊藏著巨大的成長機會。這主要得益於全食超市 (Whole Foods)、塔吉特 (Target)、CVS 等國際連鎖超市正在擴大其功能性保健區,銷售 CBD 替代補充劑和飲料品牌。主流通路的拓展顯著拓寬了消費者嘗試這些產品的機會,使其不再局限於先前限制消費者接觸功能性植物來源保健品的天然保健品零售通路。
與CBD法規澄清相關的風險
監管政策的明確化,若能為包括歐盟和美國在內的主要國際市場中CBD消費品的商業化管道鋪路,將有望大規模重新運作對CBD品牌的投資,並推動消費品領域的創新。這將加劇市場競爭,隨著資金雄厚、監管地位更加明確的CBD公司重返主流零售通路,其他CBD保健品牌將面臨激烈的競爭,爭奪消費者在緩解壓力和改善睡眠方面的支出。
新冠疫情期間的心理健康危機大大提升了消費者對便利有效的壓力、焦慮和睡眠管理解決方案的需求,推動了CBD及其替代品——適應原和植物來源保健產品類型——進入主流消費者的視野。疫情期間對心理健康的關注催生了大規模的新消費群體,他們積極購買功能性植物補充劑和飲料。在疫情後時代,壓力和焦慮的持續存在依然推動著不同族群對CBD替代保健產品的強勁需求。
在預測期內,食品業預計將佔據最大佔有率。
在預測期內,食品類產品預計將佔據最大的市場佔有率。這主要歸功於消費者對含有適應原和植物性健康成分的功能性食品和糖果甜點的強勁偏好,植物來源軟糖補充劑、含適應原的能量棒和植物來源健康零食。這些產品比膠囊或酊劑形式的補充劑更容易服用,因為它們可以作為熟悉且美味的食品食用。
在預測期內,適應原類藥物細分市場預計將呈現最高的複合年成長率。
在預測期內,適應原產品預計將呈現最高的成長率。這主要歸功於消費者對適應原草藥(如睡茄、紅景天、刺五加和聖羅勒)認知度的快速提升。這種認知度的提升得益於社交媒體的廣泛宣傳、名人代言以及臨床證據的發表,這些證據證實了適應原草藥具有調節皮質醇水平和提高壓力耐受力等功效。這些功效引起了消費者的強烈共鳴,尤其是那些長期承受壓力的商務人士和學生,他們正在尋求基於實證的天然壓力管理方案。
在預測期內,北美地區預計將佔據最大的市場佔有率。這主要歸功於以下幾點:美國擁有全球最發達的功能性保健品市場,天然保健品零售體系完善,消費者願意為適應原和植物來源舒緩壓力產品支付高價,而且像 Four Sigmatic、MUD\WTR 和 Sun Potion 這樣的領先 CBD 替代保健品牌,正在通過國內的 D2C(直接面對消費者)和零售管道創造可觀的收入。
在預測期內,亞太地區預計將呈現最高的複合年成長率。這主要歸功於中國、印度、日本和韓國等消費市場對適應原草藥和傳統藥用植物的深厚文化親和性,為CBD替代保健產品的市場推廣提供了沃土。此外,在日益都市化的亞洲市場,現代健康消費族群正在迅速壯大,他們尋求以科學檢驗的方式,透過便利的現代膳食補充劑和飲料產品,體驗傳統草藥的養生之道。
According to Stratistics MRC, the Global CBD-Alternative Wellness Products Market is accounted for $8.4 billion in 2026 and is expected to reach $32.6 billion by 2034 growing at a CAGR of 18.4% during the forecast period. CBD-alternative wellness products refer to herbal supplements, functional beverages, topical preparations, aromatherapy formulations, and edible wellness products formulated with non-cannabis bioactive ingredients including adaptogenic herbs, medicinal mushroom extracts, botanical stress-relief compounds, amino acid precursors, and micronutrient complexes that target the same wellness consumer motivations as CBD including stress reduction, sleep quality improvement, anxiety management, inflammation modulation, and mood optimization through plant-based mechanisms that avoid cannabinoid regulatory complexity and consumer stigma barriers.
Regulatory Uncertainty CBD Alternatives
Persistent CBD regulatory uncertainty across multiple international markets creating supply chain instability, labeling complexity, and distribution channel restrictions for CBD-based wellness products is directly benefiting CBD-alternative botanical wellness brands whose adaptogen, mushroom, and herbal ingredient platforms operate under clearer and more permissive regulatory frameworks. Retailers uncomfortable with CBD compliance complexity are actively expanding CBD-alternative functional wellness product assortments as lower-risk alternatives meeting the same consumer stress and anxiety relief demand.
Consumer CBD Preference Inertia
Established consumer familiarity with CBD wellness product positioning and the widely communicated endocannabinoid system mechanism of action creates consumer education requirements for CBD-alternative brands needing to build comparable consumer understanding of adaptogenic, nootropic, and medicinal mushroom ingredient mechanisms in order to justify equivalent pricing and wellness benefit positioning relative to the extensive CBD consumer communication investment made by category pioneers.
Mainstream Retail Distribution Expansion
Mainstream grocery, pharmacy, and mass market retail channel expansion for adaptogenic and functional botanical wellness products represents a major addressable market growth opportunity as Whole Foods, Target, CVS, and international grocery chains expand dedicated functional wellness sections featuring CBD-alternative supplement and beverage brands. Mainstream distribution access substantially expands trial opportunity beyond specialty natural health retail channels historically limiting functional botanical wellness category consumer reach.
CBD Regulatory Clarity Risk
Potential regulatory clarification enabling clear CBD consumer product commercialization pathways in major international markets including the European Union and United States could reactivate CBD brand investment and consumer product innovation at scale, creating intensified competitive dynamics that challenge CBD-alternative wellness brands competing for the same stress relief and sleep support consumer spending with well-capitalized CBD companies returning to mainstream retail channels with resolved regulatory positioning.
COVID-19 pandemic-era mental health crisis dramatically expanded consumer demand for accessible stress, anxiety, and sleep management wellness solutions that propelled both CBD and CBD-alternative adaptogenic and botanical wellness product categories into mainstream consumer awareness. Pandemic-driven mental wellness investment established large new consumer segments actively purchasing functional botanical supplements and beverages. Post-pandemic sustained stress and anxiety prevalence continues generating strong CBD-alternative wellness product demand across diverse demographic groups.
The edibles segment is expected to be the largest during the forecast period
The edibles segment is expected to account for the largest market share during the forecast period, due to strong consumer preference for functional food and confectionery formats incorporating adaptogenic and botanical wellness ingredients including mushroom-infused chocolates, herbal gummy supplements, adaptogen energy bars, and botanical wellness snacks that deliver wellness ingredient benefits within familiar and palatable food consumption occasions that reduce compliance barriers compared to capsule and tincture supplement delivery formats.
The adaptogens segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the adaptogens segment is predicted to witness the highest growth rate, driven by rapidly accelerating mainstream consumer familiarity with ashwagandha, rhodiola, eleuthero, and holy basil adaptogenic herbs through widespread social media education, celebrity wellness endorsement, and clinical evidence publication demonstrating cortisol modulation and stress resilience benefits that resonate strongly with chronically stressed professional and student consumer demographics seeking evidence-supported natural stress management solutions.
During the forecast period, the North America region is expected to hold the largest market share, due to the United States hosting the world's most developed functional wellness supplement market with established natural health retail infrastructure, high consumer willingness to pay premium prices for adaptogenic and botanical stress relief formulations, and leading CBD-alternative wellness brands including Four Sigmatic, MUD\WTR, and Sun Potion generating substantial domestic direct-to-consumer and retail channel revenue.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to deep cultural familiarity with adaptogenic herbs and traditional medicinal plants across Chinese, Indian, Japanese, and Korean consumer markets providing receptive foundations for CBD-alternative wellness positioning, combined with rapidly growing modern wellness consumer segments in urbanizing Asian markets seeking scientifically validated versions of traditional herbal wellness traditions through convenient contemporary supplement and beverage product formats.
Key players in the market
Some of the key players in CBD-Alternative Wellness Products Market include Nestle Health Science, Herbalife Nutrition, Amway Corporation, Gaia Herbs, Nature's Way, Garden of Life, Himalaya Wellness, Dabur India, Blackmores Ltd., Swisse Wellness, Reckitt, Unilever, P&G, Bayer AG, Pfizer Consumer Health, Jamieson Wellness, Holland & Barrett, and Now Foods.
In March 2026, Gaia Herbs launched a new Stress & Resilience adaptogen supplement collection featuring certified organic ashwagandha, reishi, and schisandra berry formulations validated through comprehensive herb quality testing protocols.
In February 2026, Holland & Barrett introduced a premium private label medicinal mushroom wellness range featuring lion's mane, reishi, and cordyceps extracts targeting cognitive performance and immune resilience across its European retail network.
In January 2026, Blackmores Ltd. expanded its botanical stress relief product portfolio with a new ashwagandha and L-theanine synergy formula targeting sleep quality improvement for Asia Pacific market launch across major pharmacy chains.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.